Iovance wins with Amtagvi and the ADC train chugs on

FromBioSpace

Start listening View podcast show

Iovance wins with Amtagvi and the ADC train chugs on

FromBioSpace

ratings:

Length:

14 minutes

Released:

Feb 21, 2024

Format:

Podcast episode

Description

This week Lori, Greg and Tyler discuss the Accelerated Approval of Amtagvi, the first one-time cell therapy for solid tumors and the first TIL therapy; the FTC and HHS probe into generic drug shortages and some recent ADC-focused raises from ProfoundBio and Firefly Bio.

Released:

Feb 21, 2024

Format:

Podcast episode

Titles in the series (46)

Unravel the business of science with BioSpace. We dive into biopharma's top stories and biggest challenges, whether it’s layoffs, pipeline shake-ups, acquisitions, new FDA approvals or how to regulate AI in drug development.

Skip carousel

Q3 earnings recap: winners, losers & surprises by BioSpace
18 min listen
Zepbound vs Wegovy: a two horse race by BioSpace
14 min listen
Artificial Intelligence, Part 1: Bias, Access, ROI, Potential Success and Failure by BioSpace
18 min listen
Integrating AI in life sciences to change employee behavior with Microsoft and IQVIA by BioSpace
21 min listen
Artificial Intelligence, Part 2: Human Interaction, Liability, and Patient Safety by BioSpace
17 min listen
Deals, Dupixent and GLP-1 drug shortages by BioSpace
17 min listen
The top life sciences startups to watch this year by BioSpace
15 min listen
Fast and furious evolution: how to ensure AI is catalyst for positive societal change with Microsoft and IQVIA by BioSpace
32 min listen
First ever CRISPR gene therapy approval: What happens next? by BioSpace
13 min listen
GLP-1 and ADC rollercoasters pick up speed by BioSpace
13 min listen
Artificial Intelligence, Part 3: Improving Communication to Impact Patient Behavior by BioSpace
17 min listen
What VCs look for when investing with MPM Capital, Endeavor Venture Fund and Two Bear Capital by BioSpace
45 min listen
Major FDA approvals for Vertex/CRISPR; bluebird gets black box warning and price scrutiny by BioSpace
17 min listen
On the ground at #JPM2024 - Day 3 highlights by BioSpace
12 min listen
Alternative funding strategies to discuss at JPM with Halia Therapeutics, the ADDF and Triumvira Immunologics by BioSpace
48 min listen
What VCs really think of the market right now with MPM Capital, Endeavor Venture Fund and Two Bear Capital by BioSpace
22 min listen
On the ground at #JPM2024 - Day 2 highlights by BioSpace
12 min listen
Grab an umbrella, it's raining ⁠IPOs⁠! by BioSpace
11 min listen
Optimistic, but for how long? Our big takeaways from #JPM2024 by BioSpace
14 min listen
Every move you make: biopharma industry under heavy scrutiny by BioSpace
16 min listen
On the ground at #JPM2024 - Day 1 highlights by BioSpace
10 min listen
Iovance wins with Amtagvi and the ADC train chugs on by BioSpace
14 min listen
What can biopharma expect from the job market? by BioSpace
18 min listen
Did WuXi Make a Whoopsie? US-China R&D Relations in Limbo by BioSpace
12 min listen
Keep calm and CAR-T on? by BioSpace
18 min listen
Sweet succession: Gonzalez, patent thickets and his triumph over biosimilars by BioSpace
14 min listen
Eyes on the prize: Novo buys Catalent by BioSpace
29 min listen
Historic approval for MASH, CAR-Ts in the spotlight by BioSpace
18 min listen
The skinny on weight loss, donanemab and the State of the Union by BioSpace
16 min listen
The ABCs of ADCs: Why antibody-drug conjugates are so hot right now by BioSpace
11 min listen

More Episodes from BioSpace

Skip carousel

Bayer Layoffs, a Big Alzheimer’s Deal and ASGCT Wrap by BioSpace
15 min listen
Women's Health: Where Politics and Science Meet by BioSpace
22 min listen
ASGCT, Adcomm for Lilly’s Donanemab, Vertex Vs. Bluebird by BioSpace
12 min listen
BioSpace Heads to #ASGCT, Along with Thousands in Cell and Gene Therapy by BioSpace
12 min listen
The IRA, BMS’ Big Cuts, First WHIM Approval by BioSpace
16 min listen
Where Do We Go From Here? The Future of Women's Health by BioSpace
22 min listen
Sanofi Layoffs, CAR-T Warnings and a New GLP-1 Player by BioSpace
18 min listen
Amylyx and ALS, Continued ADC Excitement, Dire Drug Shortages by BioSpace
20 min listen
It's a Design Problem: Women and Clinical Trials by BioSpace
20 min listen
Alphabet Soup: AACR and ACC Dominate Headlines This Week by BioSpace
17 min listen
Did WuXi Make a Whoopsie? US-China R&D Relations in Limbo by BioSpace
12 min listen
Will the IRA’s Focus on the Pharmaceutical Industry Hurt the World’s Healthcare System Instead of Helping Patients? by BioSpace
22 min listen
Bayer’s sweeping executive cuts, Wegovy’s expanding reach by BioSpace
17 min listen
Money talk: Salary trends and raises by BioSpace
15 min listen
Historic approval for MASH, CAR-Ts in the spotlight by BioSpace
18 min listen
The unintended consequences of small molecules by BioSpace
25 min listen
The skinny on weight loss, donanemab and the State of the Union by BioSpace
16 min listen
The ABCs of ADCs: Why antibody-drug conjugates are so hot right now by BioSpace
11 min listen
The gap is where the pain is: Drug pricing and patient costs by BioSpace
20 min listen
Sweet succession: Gonzalez, patent thickets and his triumph over biosimilars by BioSpace
14 min listen
Eyes on the prize: Novo buys Catalent by BioSpace
29 min listen
Balancing act: Patient access and innovation by BioSpace
21 min listen
Keep calm and CAR-T on? by BioSpace
18 min listen
What can biopharma expect from the job market? by BioSpace
18 min listen
Grab an umbrella, it's raining ⁠IPOs⁠! by BioSpace
11 min listen
Optimistic, but for how long? Our big takeaways from #JPM2024 by BioSpace
14 min listen
On the ground at #JPM2024 - Day 3 highlights by BioSpace
12 min listen
On the ground at #JPM2024 - Day 2 highlights by BioSpace
12 min listen
On the ground at #JPM2024 - Day 1 highlights by BioSpace
10 min listen
Alternative funding strategies to discuss at JPM with Halia Therapeutics, the ADDF and Triumvira Immunologics by BioSpace
48 min listen

Related podcast episodes

Skip carousel

S1, Ep. 20: Supreme Court in July!: The doctrine of the “ministerial exception” and the latest installment in the ongoing saga of challenges to the contraceptive mandate capped off this year’s Supreme Court term. Amanda and Holly give their analysis of those key cases impacting... by Respecting Religion
45 min listen
The First London Confession: The Trinity by Doctrine and Devotion
23 min listen
The Affordable Care Act Back at the Supreme Court: Explaining the latest legal challenge to the Affordable Care Act, legal experts Abbe Gluck and Ilya Shapiro joined host Jeffrey Rosen. by We the People
58 min listen
A New Class of Cell Therapies to Target Solid Tumors: In February, the U.S. Food and Drug Administration approved the first tumor-infiltrating lymphocyte, or TIL therapy, for solid tumors. The approval was hailed as a milestone that points the path forward for a new class of cell therapies for solid tum... by The Bio Report
33 min listen
Greece v. Galloway: Prayer in Government Assemblies: On May 5th 2014, the Supreme Court decided Greece v. Galloway, a landmark case about the right of prayer in government assemblies. Both sides of the argument invoked the First Amendment to make their case, but who is right and why? On this episode of... by Lawyer 2 Lawyer
32 min listen
Dr. Tim Yu on Running the First “N of 1” Drug Trial by Theory and Practice
52 min listen
PTSF90 – Colorado's Natural Medicine Healing Act and Guidelines for Emergency Ketamine Administration: In this week's Solidarity Fridays episode, Joe and Kyle discuss Colorado possibly legalizing several drugs through the Natural Medicine Healing Act, and CO also establishing guidelines around EMTs and ketamine administration. ... by Psychedelics Today
32 min listen
Think Inclusive: Facing the Anti-CRT Movement: This week, we bring you an episode from Think Inclusive, a podcast that builds bridges between families, educators, and disability rights advocates to create a shared understanding of inclusive education and what inclusion looks like in the real world. by Democracy Works
82 min listen
Volts podcast: Jack Lienke & Kirti Datla on the ridiculous (but extremely important) EPA case before the Supreme Court by Volts
82 min listen
Why Inflation Is A Problem - And Why It's Only Going To Get Worse -- John Rubino #5896: Kerry Lutz and John Rubino discussed a range of topics. They talked about the changing landscape of private sector unions and their ability to strike for higher wages, as well as the potential for inflation due to wage increases. They suggested that... by Kerry Lutz's--Financial Survival Network
45 min listen
What Christians Have in Common with LGBT Activists: Less than a year after a Supreme Court verdict gu… by Quick to Listen
31 min listen
Episode 64 by Biotech Hangout
61 min listen
Republicans play Federal Judge Whack-a-Mole by Legal AF by MeidasTouch
71 min listen
Episode 52 by Biotech Hangout
61 min listen
A Fetal Right to Life?: Abortion and the Constitution Part 2: Exploring the recent Supreme Court decision in Box v. Planned Parenthood and the “fetal personhood” debate—National Review’s David French and law professor and historian Mary Ziegler join host Jeffrey Rosen. by We the People
59 min listen
Episode 70 by Biotech Hangout
56 min listen
Can a Public Official Block You on Social Media?: Recapping oral arguments in two cases about when and how the First Amendment applies when public officials use social media by We the People
60 min listen
Episode 41 by Biotech Hangout
58 min listen
Joe Rogan’s Woeful Ignorance about Jesus (Ep. 584) by Undaunted.Life: A Man's Podcast by Kyle Thompson
63 min listen
Ep. 155: DACA + LGBTQ @ SCOTUS by Law360's Pro Say - News & Analysis on Law and the Legal Industry
42 min listen
State-Level CDR Policy Advocacy with Toby Bryce by Carbon Removal Newsroom
38 min listen
Episode 42 by Biotech Hangout
58 min listen
Eric Miller, “The Rhetoric of Religious Freedom in the United States” (Lexington Books, 2017): The recent Supreme Court Masterpiece Cakeshop ruling showed the on-going debate between religious conservatives and advocates of LGBTQ rights. Much of this debate has been about the definition of religious freedom and how to balance religious rights ag... by New Books in Religion
25 min listen
Keep calm and CAR-T on? by BioSpace
18 min listen
Abortion and Religion: Ailbhe Smyth by Freethought Radio
48 min listen
How The Supreme Court Will Shape The 2024 Election by FiveThirtyEight Politics
53 min listen
All about Dobbs: This week, Eric Kohn, Sam Gregg, and Dan Hugger discuss everything surrounding the Supreme Court’s decision in Dobbs v. Jackson Women’s Health Organization, which overturned previous precedents in Roe v. Wade and Planned Parenthood v. Casey. Why has most of the reaction been about the policy implications flowing from the decision and not what the Supreme Court actually wrote and held in Dobbs? What does that say about civics education in America right now? What should we take away from the concurring opinions filed by Chief Justice John Roberts and Justices Brett Kavanaugh and Clarence Thomas? What, if anything, was the impact of the leak of Justice Samuel Alito’s draft opinion? And how will the decision affect the nascent common-good constitutionalism movement? <a href="https://www.acton.org/audio" rel="noopener noreferrer" target="_blank">Subscribe to our podcasts</a> <a href="https://www.supremecourt.gov/opin by Acton Unwind
63 min listen
Episode 71 by Biotech Hangout
61 min listen
Episode 94 by Biotech Hangout
62 min listen
The Third Use of the Law by The London Lyceum
25 min listen

Discover this podcast and so much more

Iovance wins with Amtagvi and the ADC train chugs on

Iovance wins with Amtagvi and the ADC train chugs on

Description

Titles in the series (46)

More Episodes from BioSpace

Related podcast episodes